SMTL ID : 5t5t.2 (1 other biounit)

AMPK bound to allosteric activator

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.46 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x STU: STAUROSPORINE(Non-covalent)

STU.1: 20 residues within 4Å: Chain A: L.24, G.25, V.26, G.27, V.32, A.45, K.47, I.79, M.95, E.96, Y.97, V.98, G.101, E.102, E.145, N.146, L.148, A.158, D.159 Ligands: CL.4 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.24, A:L.24, A:V.32, A:A.45, A:K.47, A:Y.97, A:E.102, A:L.148, A:L.148, A:D.159 Hydrogen bonds: A:V.98, A:E.145 STU.11: 20 residues within 4Å: Chain D: L.24, G.25, V.26, G.27, V.32, A.45, K.47, I.79, M.95, E.96, Y.97, V.98, G.101, E.102, E.145, N.146, L.148, A.158, D.159 Ligands: CL.14 12 PLIP interactions: 12 interactions with chain D Hydrophobic interactions: D:L.24, D:L.24, D:V.32, D:A.45, D:K.47, D:Y.97, D:E.102, D:L.148, D:L.148, D:D.159 Hydrogen bonds: D:V.98, D:E.145

6 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: S.99, D.150, A.151 Ligand excluded by PLIP CL.3: 3 residues within 4Å: Chain A: F.104, I.107, G.212 Ligand excluded by PLIP CL.4: 3 residues within 4Å: Chain A: G.25, V.26 Ligands: STU.1 Ligand excluded by PLIP CL.12: 3 residues within 4Å: Chain D: S.99, D.150, A.151 Ligand excluded by PLIP CL.13: 3 residues within 4Å: Chain D: F.104, I.107, G.212 Ligand excluded by PLIP CL.14: 3 residues within 4Å: Chain D: G.25, V.26 Ligands: STU.11 Ligand excluded by PLIP

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.5: 2 residues within 4Å: Chain A: K.36, K.43 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.36, A:K.43 SO4.10: 3 residues within 4Å: Chain C: R.151, T.167, K.169 1 PLIP interactions: 1 interactions with chain C Salt bridges: C:R.151 SO4.15: 2 residues within 4Å: Chain D: K.36, K.43 2 PLIP interactions: 2 interactions with chain D Salt bridges: D:K.36, D:K.43 SO4.20: 3 residues within 4Å: Chain F: R.151, T.167, K.169 2 PLIP interactions: 2 interactions with chain F Hydrogen bonds: F:T.167 Salt bridges: F:R.151

2 x 75O: 6-chloro-5-[6-(dimethylamino)-2-methoxypyridin-3-yl]-1H-indole-3-carboxylic acid(Non-covalent)

75O.6: 14 residues within 4Å: Chain A: V.13, L.20, G.21, K.31, K.33, I.48, D.90, F.92 Chain B: V.15, R.17, D.42, N.45, V.47, I.49 11 PLIP interactions: 9 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:V.13, A:L.20, A:K.33, A:I.48, A:I.48 Hydrogen bonds: A:N.50, A:D.90 Salt bridges: A:K.31, B:R.17 pi-Cation interactions: A:K.33, B:R.17 75O.16: 14 residues within 4Å: Chain D: V.13, L.20, G.21, K.31, K.33, I.48, D.90, F.92 Chain E: V.15, R.17, D.42, N.45, V.47, I.49 11 PLIP interactions: 9 interactions with chain D, 2 interactions with chain E Hydrophobic interactions: D:V.13, D:L.20, D:K.33, D:I.48, D:I.48 Hydrogen bonds: D:N.50, D:D.90 Salt bridges: D:K.31, E:R.17 pi-Cation interactions: D:K.33, E:R.17

4 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)

AMP.7: 13 residues within 4Å: Chain C: H.150, T.199, I.203, A.204, V.224, S.225, A.226, P.228, H.297, I.311, S.313, S.315, D.316 9 PLIP interactions: 9 interactions with chain C Hydrogen bonds: C:T.199, C:A.204, C:A.204, C:S.225, C:S.313, C:S.315, C:D.316 Salt bridges: C:H.150, C:H.297 AMP.8: 12 residues within 4Å: Chain C: R.69, I.239, S.241, F.243, D.244, R.268, V.275, L.276, V.296, H.297, R.298, V.300 9 PLIP interactions: 9 interactions with chain C Hydrogen bonds: C:S.241, C:D.244, C:R.268, C:L.276, C:L.276, C:H.297, C:R.298 Salt bridges: C:R.69, C:R.298 AMP.17: 13 residues within 4Å: Chain F: H.150, T.199, I.203, A.204, V.224, S.225, A.226, P.228, H.297, I.311, S.313, S.315, D.316 10 PLIP interactions: 10 interactions with chain F Hydrogen bonds: F:T.199, F:T.199, F:A.204, F:A.204, F:S.225, F:S.313, F:S.315, F:D.316 Salt bridges: F:H.150, F:H.297 AMP.18: 12 residues within 4Å: Chain F: R.69, I.239, S.241, F.243, D.244, R.268, V.275, L.276, V.296, H.297, R.298, V.300 9 PLIP interactions: 9 interactions with chain F Hydrogen bonds: F:S.241, F:D.244, F:R.268, F:L.276, F:L.276, F:H.297, F:R.298 Salt bridges: F:R.69, F:R.298

2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.9: 15 residues within 4Å: Chain C: R.69, G.83, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153 16 PLIP interactions: 16 interactions with chain C Hydrogen bonds: C:I.87, C:T.88, C:T.88, C:D.89, C:Y.120, C:Y.120, C:V.129, C:V.129, C:H.150, C:R.151 Salt bridges: C:R.69, C:H.150, C:H.150, C:R.151, C:K.242, C:K.242 ADP.19: 15 residues within 4Å: Chain F: R.69, G.83, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153 16 PLIP interactions: 16 interactions with chain F Hydrogen bonds: F:T.86, F:I.87, F:T.88, F:T.88, F:D.89, F:Y.120, F:V.129, F:V.129, F:H.150, F:R.151 Salt bridges: F:R.69, F:H.150, F:H.150, F:R.151, F:K.242, F:K.242

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Salatto, C.T. et al., Selective Activation of AMPK beta 1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy. J. Pharmacol. Exp. Ther. (2017)

Release Date

2017-03-29

Peptides

5'-AMP-activated protein kinase catalytic subunit alpha-1: AD
5'-AMP-activated protein kinase subunit beta-1: BE
5'-AMP-activated protein kinase subunit gamma-1: CF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
A

B
B

E
B

C
C

F
C

5'-AMP-activated protein kinase catalytic subunit alpha-1

5'-AMP-activated protein kinase subunit beta-1

5'-AMP-activated protein kinase subunit gamma-1

Related Entries With Identical Sequence